Improving physical activity and psychosocial health in adolescents with type 1 diabetes
Official title: Type 1 Diabetes, Exercise and Mentoring (TEAM) Trial: A Randomized Controlled Pilot Trial Using Peer Mentorship to Increase Physical Activity and Quality of Life in Adolescents With Type 1 Diabetes
Run by University of Manitoba · NCT06296992 · Data updated 2026-11-12
This study is testing a new program where teens with type 1 diabetes get support from peers to see if it helps them be more active and feel better overall.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 17 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Manitoba Academic / other |
| Locations | 2 sites (Winnipeg, Manitoba and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | April 2027 |
| Study ends | May 2027 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT06296992 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 13-17 with type 1 diabetes who are motivated to increase their daily physical activity and currently use a continuous glucose monitor.
✕Probably not a fit
Patients who have been diagnosed with type 1 diabetes within the last 12 months or have other significant health issues, such as cancer or eating disorders, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the psychosocial health of adolescents aged 13-17 living with type 1 diabetes (T1D) by implementing a peer-led behavioral intervention designed to increase daily physical activity. Participants will be randomized to either the novel TEAM peer mentor program or standard care over a 12-week period. The study will assess the feasibility, preliminary efficacy, and safety of this intervention, while also exploring contextual factors through qualitative research. The goal is to empower adolescents with T1D to adopt healthier lifestyles and improve their quality of life.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the physical activity levels and overall psychosocial well-being of adolescents with type 1 diabetes.
How similar studies have gone: While the approach of peer mentoring in diabetes management is gaining attention, this specific model is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * want to increase their daily PA * currently use a continuous glucose monitor (CGM) Exclusion Criteria: * were diagnosed with T1D within 12 months of randomization * have diabetes secondary to medications or surgery * have cancer * evidence of drug/alcohol abuse * have an eating disorder * an orthopedic injury or illness that would limit their ability to engage in daily PA * a suicide attempt in the previous 12 months * are pregnant
Where it's running
-
the Children's Hospital Research Institute of Manitoba and the University of Manitoba
Winnipeg, Manitoba, Canada Recruiting -
Trillium Health Partners
Mississauga, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Jonathan McGavock — University of Manitoba / the Children's Hospital Research Institute of Manitoba
- Study coordinator: Jonathan McGavock, PhD
- Email: jmcgavock@chrim.ca
- Phone: 204-789-3591
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity
This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.
-
Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes
This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes
This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.
-
Think-Find-Solve activities for insulin self-management in children with type 1 diabetes
A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.
-
Near-sensor insulin delivery with CGM in people with type 1 diabetes
A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.